Clinical Trial Update: Equivalency Study of Two Formulations of Mometasone Furoate Nasal Spray (Study P04419) [Phase 3]

View source ↗

Summary

This update reports the completion of a Phase 3 equivalency study comparing two formulations of mometasone furoate nasal spray in perennial allergic rhinitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis Perennial

Drugs mentioned

• Mometasone furoate nasal spray (mometasone furoate)

Snippet

Sponsor: Organon and Co | Conditions: Rhinitis, Allergic, Perennial | Phase 3 | Status: COMPLETED